ISRCTN52748737已完成未知
Comparison of the influence of low-dose supplementation with potassium citrate or potassium chloride on blood pressure, plasma and erythrocyte electrolyte concentrations and bone health biomarkers
King's College London (UK)0 个研究点目标入组 120 人开始时间: 2006年4月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
2008 results in https://doi.org/10.1017/S0007114507864853 (added 06/08/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •To take part in the study, participants will be aged between 22 and 65 years and will have a body mass index (BMI) between 19 and 35 kg/m^2 and alcohol consumption of no more than 21 units (women) or 28 units (men) per week. Volunteers eligible for the study will have the average self-measured systolic blood pressure <160 and average self-measured diastolic blood pressure <105 mmHg (an average of 20 readings for both systolic and diastolic blood pressure). Those with blood pressure levels higher than these values will be advised to contact their general practitioners.
- •Subjects taking medications for which potassium supplementation is not contraindicated, or mineral and vitamin supplements, will be allowed to participate in the study with the provision that they will not discontinue to use these products.
排除标准
- •The main exclusion criteria will be diseases or conditions that might involve collateral effects from potassium supplementation or interfere with its metabolism. These will be insulin dependent diabetes mellitus, non-insulin dependent diabetes mellitus, diabetes insipidus, cardiovascular diseases (including events of cardiac arrhythmia and peripheral arterial disease) or previous cardiovascular events, any kind of renal diseases, metabolic acidosis, current peptic ulcers, dysphagia, general digestive problems, gastric surgery, pregnancy and lactation. Women planning to become pregnant will also be excluded.
- •Other exclusion criteria will be the use of antihypertensive drugs, changes in lifestyle (e.g. dieting, start of new medication), the use of drugs known to interfere with potassium metabolism (cyclosporin, heparin, digoxin, anticholinergics) and prolonged use of non-steroidal anti-inflammatory drugs.
研究者
相似试验
尚未招募
3 期
Evaluation of the effectiveness of low-dose ketamine (Sub dissociative) with dexmedetomidine in controlling pain in patients with limb trauma referred to emergency departmentIRCT20220120053770N1Tehran University of Medical Sciences258
招募中
不适用
Old drug in new dose: Olanzapine in chemotherapy induced nausea & vomiting, does dose matters?CTRI/2020/02/023589Sandip Mukhopadhyay100
尚未招募
4 期
Comparing the effect of low dose and standard dose Cyproheptadine on BMI enhancement in children aged 2-10 and evaluation of its side effectsthinness.IRCT20240213060992N1Shahre-kord University of Medical Sciences90
招募中
3 期
The effect of different doses of castor oil capsule (Gelax) on Bishop's score and some delivery outcomesIRCT20190717044248N1Rafsanjan University of Medical Sciences90
招募中
3 期
Thalidomide for patients with Thalassemia majorCTRI/2022/05/042781Pahuja trust for blood disorders
